Biotech

All Articles

' All palms on deck' at Lilly as peers target weight problems market

.Chief executive officer David Ricks may find the providers setting up outdoors tents at basecamp be...

Entero giving up personnel, abandoning office and pausing R&ampD

.Bed mattress Liquidators has actually switched Entero Therapeutics white as a piece. The lender bou...

Exelixis falls ADC after deciding it's no suit for Tivdak

.Exelixis is actually quiting on its own tissue variable (TF)- targeting antibody-drug conjugate aft...

Relay dislikes SHP2 inhibitor after Genentech leaves

.3 weeks after Roche's Genentech device bowed out an SHP2 inhibitor deal, Relay Therapeutics has val...

Stoke's Dravet syndrome med launched of predisposed professional hold

.Stoke Rehabs' Dravet syndrome medicine has actually been actually without a partial hold, removing ...

Fierce Biotech's Gabrielle Masson presents Tough 15 at NYSE

.Strong Biotech Associate Publisher Gabrielle Masson presented the 2024 course of Ferocious 15 champ...

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH possibility

.Novo Nordisk has actually axed its once-monthly twin GLP-1/ GIP receptor agonist, finishing (PDF) p...

Daiichi pays Merck $170M to develop bronchi cancer cells T-cell engager contract

.Merck &amp Co. has promptly recouped several of the prices of its own Spear Rehabs acquistion, attr...

BioMarin stops preclinical gene therapy for heart disease

.After BioMarin carried out a spring season clean of its pipeline in April, the company has decided ...

Eisai vegetations molecular glue SEED along with $1.5 B biobucks work

.Significant Pharmas remain caught to the concept of molecular adhesive degraders. The current firm ...